There are currently 8 ongoing clinical trials involving Craniopharyngioma
Of the 8 trials,5 trials are in Phase II
Furthermore, 2 trials are in Phase 0
The global pharmaceutical industry is steadily developing new drugs for Craniopharyngioma, an Oncology indication. The largest number of ongoing clinical trials of Craniopharyngioma is conducted in North America. Asia-Pacific is the other prominent region involved in Craniopharyngioma-related drug trials.
Craniopharyngioma related clinical trial sponsors
West China Hospital of Sichuan University, Nascent Biotech Inc, Rhythm Pharmaceuticals Inc, Suzhou Neupharma Co Ltd, and Children's Hospital Colorado are a few notable clinical trial sponsors involved in Craniopharyngioma. A clinical trial sponsor can be a Company, Government, Individual, or Institution.
China
Switzerland
United States of America
United States of America
United States of America
United States of America
Germany
France
Switzerland
United Kingdom
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer